Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 12,424.00
Ask: 12,426.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies cuts Persimmon; BoA cuts GSK

Mon, 05th Dec 2022 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

Bank of America cuts Vodafone price target to 130 (140) pence - 'neutral'

----------

Bank of America cuts BT Group price target to 187 (223) pence - 'buy'

----------

Bank of America cuts GSK to 'underperform' (neutral) - price target 1,450 (1,640) pence

----------

Bank of America raises AstraZeneca price target to 14,500 (12,500) pence - 'buy'

----------

Bernstein cuts Reckitt Benckiser price target to 6,100 (6,400) pence - 'market-perform'

----------

Bernstein cuts Unilever to 'market-perform' (outperform) - price target 3,500 (4,280) pence

----------

RBC raises Compass Group price target to 1,625 (1,575) pence - 'underperform'

----------

JPMorgan raises B&M price target to 555 (414) pence - 'overweight'

----------

JPMorgan raises Sainsbury price target to 206 (161) pence - 'underweight'

----------

JPMorgan raises Tesco price target to 270 (240) pence - 'overweight'

----------

Jefferies raises Barratt Developments price target to 452 (356) pence - 'hold'

----------

Jefferies cuts Persimmon to 'hold' (buy) - price target 1,436 (1485) pence

----------

Jefferies raises Taylor Wimpey price target to 124 (105) pence - 'buy'

----------

Jefferies raises Berkeley Group price target to 4,554 (4,330) pence - 'buy'

----------

Jefferies raises CRH price target to 51.60 (50.30) EUR - 'buy'

----------

Jefferies cuts Spirax-Sarco price target to 9,910 (11,460) pence - 'underperform'

----------

FTSE 250

----------

Bank of America raises Helios Towers price target to 180 (175) pence - 'buy'

----------

Morgan Stanley cuts Hays price target to 145 (146) pence - 'overweight'

----------

Morgan Stanley cuts PageGroup to 'equal-weight' (overweight) - price target 505 (510) pence

----------

UBS raises easyJet price target to 600 (565) pence - 'buy'

----------

Jefferies raises Travis Perkins price target to 931 (811) pence - 'hold'

----------

Jefferies raises Redrow price target to 592 (491) pence - 'buy'

----------

Jefferies raises Crest Nicholson price target to 278 (229) pence - 'buy'

----------

Jefferies raises Vistry price target to 829 (744) pence - 'buy'

----------

Jefferies raises Bellway to 'buy' (hold) - price target 2,458 (1,928) pence

----------

SMALL CAP

----------

Citigroup cuts Gamma Communications price target to 1,320 (1,650) pence - 'buy'

----------

Berenberg raises Tharisa price target to 260 (240) pence - 'buy'

----------

Deutsche Bank cuts Ferguson price target to 9,630 (9,960) pence - 'hold'

----------

Barclays raises AIB price target to 3.80 (3.40) EUR - 'equal weight'

----------

Jefferies cuts Watkin Jones to 'hold' (buy) - price target 111 (225) pence

----------

Jefferies cuts Kingspan to 'underperform' (hold) - price target 45.90 (63.60) EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.